HOME >> BIOLOGY >> NEWS
Study Ensures Effective Ways To Measure Macular Pigment Density

(FT. LAUDERDALE, Fla., May 9, 1999) - Dietary lutein and zeaxanthin are the major determinants to explain macular pigment optical density (MPOD), according to research presented today at the Association for Research in Vision and Ophthalmology 1999 annual meeting. The study was the largest ever conducted to examine the relationship between dietary, medical, physical and lifestyle factors, and macular pigment density, thought to be protective in age-related macular degeneration (AMD).

"Results confirmed and expanded upon what's already known about the determinants of macular pigment density. Dietary lutein and zeaxanthin explained the greatest amount of macular pigment density variance, followed by serum lutein levels," said Thomas Ciulla, M.D., Retinal Specialist, Indiana University School of Medicine and Ophthalmology Department in Indianapolis, Ind.

Ciulla and his colleagues examined the MPOD of a cross sectional population of 280 healthy men and women in Indianapolis. They determined that dietary lutein and zeaxanthin, serum lutein and eye color are the factors most strongly associated with macular pigment density. Ciulla cautions, however, that, taken together, these factors explained only 19.7 % variance in MPOD.

Lutein and zeaxanthin are concentrated in retinal macular pigment and accumulation is thought to be dependent on dietary intake. Macular pigment may filter blue light that damages photoreceptors and the retinal pigment epithelium. In addition, carotenoids may limit oxidant stress resulting from metabolism and light, acting as antioxidants.

In this study, serum concentrations for lutein, zeaxanthin and beta-carotene were measured by HPLC, and MPOD was measured by heterochromatic flicker photometry. Dietary patterns and demographic/medical characteristics were determined by questionnaire. This method of study was a non-invasive way to measure MPOD and also showed that MPOD can be rel
'"/>

Contact: Anne Tramer
atramer@selz.com
312-372-7090
Selz/Seabolt Communications
8-May-1999


Page: 1 2

Related biology news :

1. Study: Emission of smog ingredients from trees is increasing rapidly
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. Study reveals why eyes in some paintings seem to follow viewers
4. Study by Israeli scientists provides insight on DNA code
5. Study reveals first genetic step necessary for prostate cancer growth
6. Study of flu patients reveals virus outsmarting key drug
7. Study in Science reveals recreational fishing takes big bite of ocean catch
8. Study suggests cell-cycle triggers might be cancer drug targets
9. Study narrows search for genes placing men at increased risk for prostate cancer
10. Study links high carbohydrate diet to increased breast cancer risk
11. Study explains spatial orientation differences between sexes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities ... (physiological and behavioral), by technology (fingerprint, AFIS, iris recognition, ... recognition, and others), by end use industry (government and ... immigration, financial and banking, and others), and by region ... , Asia Pacific , and ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , ... of Cancer Research, London (ICR) and ... with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple ... as MUK nine . The University of ... is partly funded by Myeloma UK, and ICR will perform ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... optimization firm for the life sciences and healthcare industries, announces a presentation by ... Francisco. , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present ...
(Date:10/9/2017)... , ... October 09, 2017 , ... ... four-tiered line of medical marijuana products targeting the needs of consumers who are ... of Kindred takes place in Phoenix, Arizona. , As operators of two successful ...
Breaking Biology Technology:
Cached News: